Summary & Overview
HCPCS G9503: Patient Taking Tamsulosin Hydrochloride
HCPCS Level II code G9503 identifies documentation that a patient is taking tamsulosin hydrochloride, a medication typically used for lower urinary tract symptoms related to benign prostatic hyperplasia. Nationally, medication-status codes like G9503 support accurate clinical records, medication reconciliation, and quality reporting by signaling active pharmacologic therapy for a specific condition.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code's clinical context and service settings, plus what to expect in a fuller analysis: payer coverage considerations, coding and billing nuances, and how this documentation code integrates with medication management workflows. This publication frames G9503 as part of broader efforts to standardize documentation of active medications, which can affect quality measures, continuity of care, and administrative processing across payers.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service-line specifics; those elements are noted as unavailable where relevant. The focus here is on the code's purpose, clinical relevance, and typical ambulatory use.
Billing Code Overview
HCPCS Level II code G9503 indicates a patient taking tamsulosin hydrochloride. This code denotes documentation that the patient is currently prescribed and using the medication tamsulosin hydrochloride, a selective alpha-1 adrenergic receptor antagonist commonly used to treat lower urinary tract symptoms associated with benign prostatic hyperplasia.
-
Service type: Medication status documentation and medication management related to tamsulosin hydrochloride
-
Typical site of service: Outpatient clinic or other ambulatory care settings where medication reconciliation and clinical documentation occur
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a male aged 50–75 with lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH) who is prescribed tamsulosin hydrochloride for symptomatic relief. The clinical workflow begins with an outpatient urology or primary care visit where the patient reports urinary frequency, nocturia, weak stream, and incomplete emptying. A focused history, medication review, and symptom scoring (eg, International Prostate Symptom Score) are completed. A physical exam including digital rectal exam is performed, and urinalysis is ordered to rule out infection. After discussion of medical therapy, tamsulosin hydrochloride is initiated at the recommended dose. Follow-up occurs in 2–6 weeks to assess efficacy and adverse effects (orthostatic hypotension, dizziness, ejaculatory dysfunction). Ongoing monitoring includes blood pressure checks, review of concurrent medications (particularly antihypertensives and PDE-5 inhibitors), and periodic assessment of renal function if clinically indicated. Typical sites of service are outpatient clinic, urology practice, or ambulatory care centers. Common care team members include urologists, family medicine physicians, nurse practitioners, and clinical pharmacists managing drug interactions and counseling on adherence.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required to manage medication-related issues or complex counseling is substantially greater than typical for a visit related to initiation or management of . |